About La Mantus Pharmaceuticals Private Limited
Data last updated:
La Mantus Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 11 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33309DL2017PTC317355. Its GSTIN is 10AADCL3125D1ZD (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saket Kumar Singh and Monika Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 107 1st Floor Plot No – 1 Ajnara Tower L.S.C. Savita Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹56.97 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.11 Lakh (net margin 2%) and EBITDA of ₹1.54 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lemantus.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressF – 107 1st Floor Plot No – 1 Ajnara Tower L.S.C. Savita Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of La Mantus Pharmaceuticals Private Limited
The main business activity of La Mantus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of La Mantus Pharmaceuticals Private Limited FY 2025 filings available
La Mantus Pharmaceuticals Private Limited reported revenue of ₹56.97 Lakh (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of La Mantus Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 17% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of La Mantus Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.54 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of La Mantus Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of La Mantus Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aveza Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Jaipur, Rajasthan, India |
| Egzeon Pharmaceuticals Private Limited | ₹57.23 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Ambala Cantt, Haryana, India |
| Novostar Pharmaceuticals Private Limited | ₹57.22 Lakh (FY 2025) | •••• | •••• | 119.0% | •••• | Ambala, Haryana, India |
| Capricon Pharmaceuticals Private Limited | ₹57.19 Lakh (FY 2018) | •••• | •••• | -59.0% | •••• | New Delhi, Delhi, India |
| Ms Bio Pharmaceuticals Private Limited | ₹57.16 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| La Mantus Pharmaceuticals Private Limited this company | ₹56.97 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | New Delhi, Delhi, India |
| Beecan Pharmaceuticals Private Limited | ₹56.75 Lakh (FY 2024) | •••• | •••• | 283.0% | •••• | Chandigarh, India |
| Clarianz Pharmaceuticals Private Limited | ₹56.53 Lakh (FY 2022) | •••• | •••• | -12.0% | •••• | Latur, Maharashtra, India |
| Medimaster Pharmaceuticals Private Limited | ₹56.17 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Motihari, Bihar, India |
| Vithai Pharmaceuticals Private Limited | ₹56.12 Lakh (FY 2024) | •••• | •••• | 173.0% | •••• | Mumbai, Maharashtra, India |
| Michaels Pharmaceuticals Private Limited | ₹56.08 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below La Mantus Pharmaceuticals by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals Private Limited is audited by ASHWANI AGGARWAL for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHWANI AGGARWAL | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saket Kumar Singh | Director | 11 May 2017 | 9 Years 5 Months | Current |
| Monika Kumari | Director | 11 May 2017 | 9 Years 5 Months | Current |
| Rohan Rajwardhan | Director | 11 May 2017 | 9 Years 5 Months | Current |
Ownership and Shareholding of La Mantus Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at La Mantus Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to La Mantus Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Monika Kumari was appointed as Director on 11 May 2017.
Credit Ratings, Litigation & Regulatory Alerts for La Mantus Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by La Mantus Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of La Mantus Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCL3125D1ZD | Bihar | Active | 23 Jun 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of La Mantus Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about La Mantus Pharmaceuticals Private Limited
La Mantus Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 11 May 2017 (9+ years old) and is registered under CIN U33309DL2017PTC317355.
La Mantus Pharmaceuticals reported revenue of ₹56.97 Lakh for FY 2024 (down 17% YoY).
La Mantus Pharmaceuticals has 3 current directors:
- Saket Kumar Singh - Director
- Monika Kumari - Director
- Rohan Rajwardhan - Director
La Mantus Pharmaceuticals reported a net profit of ₹1.11 Lakh (net margin 2%) and EBITDA of ₹1.54 Lakh (EBITDA margin 2.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of La Mantus Pharmaceuticals is -6% over three years and -11% over five years. In the latest year (FY 2024) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of La Mantus Pharmaceuticals is 10AADCL3125D1ZD, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of La Mantus Pharmaceuticals is U33309DL2017PTC317355. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
La Mantus Pharmaceuticals was incorporated on 11 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of La Mantus Pharmaceuticals by revenue are Aveza Pharmaceuticals Private Limited, Egzeon Pharmaceuticals Private Limited, Novostar Pharmaceuticals Private Limited, Capricon Pharmaceuticals Private Limited, Ms Bio Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Animal Pharma, Pharmaceuticals).
Monika Kumari was appointed as Director on 11 May 2017. Rohan Rajwardhan was appointed as Director on 11 May 2017. Saket Kumar Singh was appointed as Director on 11 May 2017.
La Mantus Pharmaceuticals can be reached through the website lemantus.com. Its registered office is in New Delhi, Delhi, India.